Butterfly Network, Inc. has announced impressive financial results for the third quarter of 2026, showcasing a significant increase in revenue and improved profitability metrics. The company reported quarterly revenue of $32.6 million, surpassing its guidance and reflecting a 52% increase from the previous year. This growth is largely attributed to its innovative embedded ultrasound technology and a strong performance in the U.S. market.

Joseph DeVivo, President and CEO of Butterfly Network, expressed optimism about the company’s trajectory. He stated, “Our third quarter results came in ahead of guidance on both revenue and adjusted EBITDA, and we posted the highest gross margin in Butterfly’s history.” The company recorded a gross margin of 73%, the highest in its history, indicating improved operational efficiency and product demand.

Background

Butterfly Network, Inc. operates in the X-Ray Apparatus & Tubes & Related Irradiation Apparatus sector, as classified under SIC 3844. The company trades on the New York Stock Exchange under the ticker symbol BFLY. Established as a pioneer in semiconductor-based ultrasound devices, Butterfly has been at the forefront of integrating advanced technology with medical imaging solutions.

Recent filings indicate that Butterfly has been actively engaging in various operational strategies to enhance its market position. The company’s latest 8-K filing, dated October 29, 2026, details its financial performance and strategic initiatives.

What the Filing Says

The filing reveals that Butterfly Network's revenue for the third quarter was driven by its embedded ultrasound technology, which has gained traction in the healthcare sector. DeVivo noted, “We saw strength across our business,” highlighting the successful conversion of enterprise pipeline opportunities into signed deals.

In addition to revenue growth, the company achieved a net loss of $12.8 million, a significant reduction from a loss of $34.0 million in the same quarter last year. This improvement reflects the company's ongoing efforts to streamline operations and enhance profitability.

Impact

The results are likely to have a ripple effect across the medical imaging industry, particularly among competitors in the X-ray apparatus sector. Butterfly's advancements in ultrasound technology may prompt other companies to innovate or adjust their strategies to maintain market share. The success of Butterfly's Embedded technology could also inspire new partnerships and collaborations within the healthcare technology landscape.

What's Next

Looking ahead, Butterfly Network has increased its full-year revenue and adjusted EBITDA guidance, signaling confidence in its growth trajectory. The filing does not specify the next steps, but the company is expected to continue its focus on expanding its market reach and enhancing product offerings.